Glaucoma is a group of neurodegenerative disease linked with imbalance in the aqueous humor flow due to resistance in the aqueous drainage system. This increases the intraocular pressure (IOP), which causes damage to the optic nerve head and leads to irreversible blindness. As IOP is the only treatable risk factor for glaucoma, its 24 hours biorhythm need to be understood before managing it. Monitoring IOP is a critically important part in the management of glaucoma. Various approach and technology have been initiated and on-going for a frequent, round-the-clock IOP measurement to determine the IOP peaks and fluctuations. We review the current innovative approach and its importance as well as discussing the shortcomings of each method to ob...
Stefan De Smedt Department of Ophthalmology, AZ St Maarten, Mechelen, Belgium Abstract: Glau...
Current management of glaucoma entails the medical, laser, or surgical reduction of intraocular pres...
Purpose of reviewTo review current status and future of ambulatory 24-h intraocular pressure monitor...
Glaucoma is a group of neurodegenerative disease linked with imbalance in the aqueous humor flow due...
Intraocular pressure (IOP), like other biological parameters, has a 24-hour rhythm with physiologica...
Intraocular pressure (IOP) is the only treatable risk factor for glaucoma. Yet, current glaucoma man...
Glaucoma is the leading cause of irreversible blindness and vision loss in the world. Although intra...
The present review casts a critical eye on intraocular pressure (IOP) monitoring and its value in cu...
Over the past decade, results from prospective, randomized, clinical trials have confirmed the value...
Glaucoma is one of the leading causes of blindness worldwide. Recent studies suggest that intraocula...
Glaucoma is the second leading cause of blindness, and the number of people diagnosed is expected to...
Glaucoma is an optic neuropathy often associated with increased intraocular pressure (IOP) that can ...
Glaucoma is the leading cause of irreversible blindness, affecting around 80 million people worldwid...
AIM: To analyze the value of 24-hour intraocular pressure(IOP)monitoring in suspected glaucoma patie...
Higher intraocular pressure (IOP) is a risk factor for the development and progression of glaucomato...
Stefan De Smedt Department of Ophthalmology, AZ St Maarten, Mechelen, Belgium Abstract: Glau...
Current management of glaucoma entails the medical, laser, or surgical reduction of intraocular pres...
Purpose of reviewTo review current status and future of ambulatory 24-h intraocular pressure monitor...
Glaucoma is a group of neurodegenerative disease linked with imbalance in the aqueous humor flow due...
Intraocular pressure (IOP), like other biological parameters, has a 24-hour rhythm with physiologica...
Intraocular pressure (IOP) is the only treatable risk factor for glaucoma. Yet, current glaucoma man...
Glaucoma is the leading cause of irreversible blindness and vision loss in the world. Although intra...
The present review casts a critical eye on intraocular pressure (IOP) monitoring and its value in cu...
Over the past decade, results from prospective, randomized, clinical trials have confirmed the value...
Glaucoma is one of the leading causes of blindness worldwide. Recent studies suggest that intraocula...
Glaucoma is the second leading cause of blindness, and the number of people diagnosed is expected to...
Glaucoma is an optic neuropathy often associated with increased intraocular pressure (IOP) that can ...
Glaucoma is the leading cause of irreversible blindness, affecting around 80 million people worldwid...
AIM: To analyze the value of 24-hour intraocular pressure(IOP)monitoring in suspected glaucoma patie...
Higher intraocular pressure (IOP) is a risk factor for the development and progression of glaucomato...
Stefan De Smedt Department of Ophthalmology, AZ St Maarten, Mechelen, Belgium Abstract: Glau...
Current management of glaucoma entails the medical, laser, or surgical reduction of intraocular pres...
Purpose of reviewTo review current status and future of ambulatory 24-h intraocular pressure monitor...